BioIQ boosts employee wellness offerings with home test kits
SANTA BARBARA, Calif. BioIQ, a provider of health test kits and medical data management solutions, on Tuesday announced that Scripps Health has elected to enhance its employee wellness program for the second consecutive year by offering home test kits from BioIQ and Alere.
Scripps employees who choose to participate in the organization’s wellness program are required to start by completing an annual wellness assessment, which checks their biometric numbers to monitor their risk for heart disease, stroke, diabetes and other serious conditions. Employees may complete their annual assessment on site at a Scripps facility, or if they prefer, via a home test kit at their convenience.
“Scripps’ goal with the home test kits was to achieve an overall employee participation rate of 50 percent for the diabetes and cholesterol screening,” said Hamilton Mears, manager of corporate wellness and health promotion at Scripps Health. “The home testing program contributed toward our efforts to reach this goal.”
With the BioIQ home test kits, participants supply a small blood sample via a prick of the finger and mail the samples to a certified laboratory.
Home Diagnostics reports revenue loss, gain in retail sales
FORT LAUDERDALE, Fla. Home Diagnostics, Inc. on Thursday posted total revenue of $24.6 million for the first quarter ended March 31, representing a decrease of 2.1%.
However, retail channel sales were up 25.2%, driven by the continued nationwide rollout of the TRUEresult and TRUE2go blood glucose monitoring systems and the rollout of TRUEtrack at Walmart, HDI stated.
“Our first quarter results are slightly better than our guidance,” stated Joseph Capper, HDI president and CEO. “While we are not satisfied with our current results, we are weathering the economic downturn substantially better than several of the larger branded companies in the industry, who reported double digit revenue declines in the first quarter. We view this as an indicator of the strength of our value offering, especially given the challenging economic environment, which we believe is driving patients to lower cost alternatives.”
In March 2009, the company received 510(k) clearance from the Food and Drug Administration for TRUEbalance, the company’s new low-cost, no-coding meter. TRUEbalance broadens the company’s no-code product portfolio to meet the specific needs of certain segments of the market. HDI anticipates launching TRUEbalance in the second quarter of 2009.
Insight Pharmaceuticals acquires Church & Dwight OTC products
LANGHORNE, Pa. Insight Pharmaceuticals on Wednesday announced the acquisition of seven brands from Church & Dwight, including Auro-Dri, an ear-drying aid; Boil Ease, a boil pain-relief product; Dermarest eczema treatment; the Gentle Naturals line of baby care products; lice treatment brand Pronto Plus; the liquid bandage Skin Shield; and the eye ointment Stye.
Financial terms were not disclosed.
The addition of the Church & Dwight brands to the Insight portfolio will strengthen its position in the OTC pharmaceuticals arena, Insight stated.